Brain AT2 receptor mediate vasodepressor response to footshocks: Role of kinins and nitric oxide

Brain Research Bulletin

Volumn 51, Issue 4, 2000, Pages 339-343

  Israel, Anita ^a   Sosa, Beatriz ^b   Gutierez, Carmen Ines ^c  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Universidad Nacional Experimental Francisco de Miranda   (Venezuela)

^c UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

Author keywords

Angiotensin II receptor subtypes; Footshocks; Kinins; Losartan; PD 123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ICATIBANT; KININ; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC SHOCK; HEART RATE; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BRADYKININ; BRAIN; ELECTROSHOCK; ENZYME INHIBITORS; EXTREMITIES; HEART RATE; IMIDAZOLES; INJECTIONS, INTRAVENTRICULAR; LOSARTAN; MALE; NITRIC OXIDE SYNTHASE; NITROARGININE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTOR, BRADYKININ B2; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ;

EID: 0033994206     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00244-0     Document Type: Article

References (41)

1. Antonaccio M.J., Kervin L. Pre- and postjunctional inhibition of vascular function by captopril in SHR implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril. Hypertension. 3:1981;I54-I62.
2. Barbella Y., Cierco M., Israel A. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on drinking behavior and renal actions of central administered renin. Proc. Soc. Exp. Biol. Med. 202:(4):1993;401-406.
3. 2-receptor mediates endothe-lium-dependent dilation of rat brain arterioles. FASEB J. 6:1992;A1264.
4. Brosnihan K.B., Li P., Ferrario C.M. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 27:1996;523-528.
5. Bunkenburg B., Schnell C.H., Baum H.P., Cumin F., Wood J.M. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences. Hypertension. 18:1991;278-288.
6. Caligiorne S.M., Santos R.A.S., Campagnole-Santos M.J. Cardiovascular effects produced by bradykinin microinjection into the nucleus tractus solitarii of anesthetized rats. Brain Res. 720:1996;183-190.
7. Carini D.J., Duncia J.V., Aldrich P.E., Chiu A.T., Johnson A.L., Pierce M.E., Price W.A., Santella J.B. III, Wells G.S., Wexler R.R., et al. Nonpeptide angiotensin II receptor antagonists The discovery of a series of N-(biphenylylmethyl) imidazoles as potent, orally active antihypertensives . J. Med. Chem. 34:1991;2525-2547.
8. Chaki S., Inagami T. New signaling mechanism of angiotensin II in neuroblastoma Neuro-sA cells Activation of soluble guanylyl cyclase via nitric oxide synthesis . Mol. Pharmacol. 43:1993;603-608.
9. 1 receptor on the cardiovascular response to footshock. Eur. J. Pharmacol. 251:1994;103-106.
10. 1 expression. Hypertension. 23:1994;587-592.
11. Fregly M.J., Rowland N.E. Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats. Brain Res. Bull. 27:1991;976-1000.
12. 2 subtypes . Life Sci. 44:1989;1645-1653.
13. 2+. Am. J. Physiol. 259:1990;F269-F278.
14. Gelband C.H., Sumners C., Lu D., Raizada M.K. Angiotensin receptors and norepinephrine neuromodulation Implications of functional coupling . Reg. Pept. 73:1998;141-147.
15. Hecker M., Porsti Y., Busse R. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors. Braz. J. Med. Biol. Res. 27:1994;1917-1921.
16. 2 receptor antagonist. Eur J. Pharmacol. 275:1995;277-282.
17. Ichiki T., Labosky P.A., Shiota S., Okuyama S., Imagawa Y., Fogo A., Niimura F., Ichikawa Y., Hogan B.L., Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 377:1995;748-750.
18. Kadekaro, M.; Terrel, M. L.; Liu, H.; Gestl, S.; Bui, V.; Summy-Long, J. Y. Effect of L-NAME on cerebral metabolic, vasopressin, oxytocin, and blood pressure responses in hemorrhaged rats. Am. J. Physiol. 274 (Reg. Integr. Comp. Physiol. 43):R1070-R1077; 1998.
19. Lee J.H., Konarska M., McCarty R. Physiological responses to acute stress in alloxan and streptozotocin diabetic rats. Physiol. Behav. 45:1989;483-489.
20. Liu J.-L., Murakami H., Zucker H.I. Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ. Res. 82:1998;496-502.
21. Lo W.-C., Jan C.-R., Wu S.-N., Tseng C.-J. Cardiovascular effects of nitric oxide and adenosine in the nucleus tractus solitarii of rats. Hypertension. 32:1998;1034-1038.
22. Millatt L.J., Abdel-Rahman E.M., Siragy H.M. Angiotensin II and nitric oxide A question of balance . Reg. Pept. 81:1999;1-10.
23. 1 receptor Gain of-function study using gene transfer . Proc. Natl. Acad. Sci. USA. 92:1995;10663-10667.
24. Obermüler N., Unger Th., Culman J., Gohlke P., Bottari S.P. Distribution of angiotensin II receptor subtypes in rat brain nuclei. Neurosci. Lett. 132:1991;11-14.
25. Phillips M.I. Functions of angiotensin in the central nervous system. Annu. Rev. Physiol. 49:1987;413-435.
26. 1 receptors in the supraoptic nucleus. J. Pharmacol. Exp. Ther. 267:1993;567-574.
27. 1 receptors and angiotensin hypertensive rats. Mukhopadhyay A.K., Raizada M.K. Current concepts Tissue renin-angiotensin system as local regulators in reproductive and endocrine organs . 1994;331-348 Plenum, New York.
28. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Moreno V., Martinez-Murillo R., Polak J.M., Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. London B. Biol Sci. 345:1994;175-221.
29. Saiki Y., Watanabe T., Tan N., Matsuzaki M., Nakamura S. Role of central ANG II receptors in stress-induced cardiovascular and hyperthermic responses in rats. Am. J. Physiol. 272:1997;R26-R33.
30. Scheuer, D. A.; Perrone, M. H. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angio-tensin. Am. J. Physiol. (Reg. Integr. Comp. Physiol. 33) 264:R917-R923; 1993.
31. Schmid H.A., Schafer F., Simon E. Opposite effects of angiotensin II and nitric oxide on neurons in the duck subfornical organ. Neurosci. Lett. 187:1995;149-152.
32. Scicli A.G., Carretero O.A. The brain kallikrein-kinin system. A possible role in blood pressure regulation. Hypertension. 15:1990;413-414.
33. Severs W.B., Summy-Long J., Taylor J.S., Connor J.D. A central effect of angiotensin Release of pituitary pressor material . J. Pharmacol. Exp. Ther. 174:1970;27-34.
34. Seyedi N., Xu X., Nasjletti A., Hintze T.H. Coronary kinin generating mediates nitric oxide release after angiotensin receptor stimualtion. Hypertension (Dallas). 26:1995;164-170.
35. 2 production in conscious rats. J. Clin. Invest. 97:1996;1978-1982.
36. 2) angiotensin receptor. Proc. Natl. Acad. Sci. 96:1999;6506-6510.
37. Sumners C., Phillips I.M. Central injection of angiotensin II alters catecholamine activity in rat brain. Am. J. Physiol. 244:1983;R257-R263.
38. 2) in rat brain. Am. J. Physiol. 261:1991;R209-R216.
39. 2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm. Pharmacol. Lett. 3:1993;24-27.
40. Wong P.C., Hart S.D., Zaspel A.M., Chiu A.T., Ardecky R.J., Smith R.D.R., Timmermans P.B.M.W.M. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands DuP 753 (AII-1) and PD 123177 (AII-2) . J. Pharmacol. Exp. Ther. 255:1990;584-592.
41. Yang E.K. II, Lee W.J., Park Y.Y., Ahn D.K., Park J.S., Kim H.J. Effect of chronic central administration of losartan on the cardiovascular and hormonal responses to hemorrhage in conscious rats. Reg. Pept. 67:1996;107-113.